These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9422362)

  • 41. Further studies of the role of hyperthermia in methamphetamine neurotoxicity.
    Bowyer JF; Davies DL; Schmued L; Broening HW; Newport GD; Slikker W; Holson RR
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1571-80. PubMed ID: 8138969
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice.
    Cadet JL; Sheng P; Ali S; Rothman R; Carlson E; Epstein C
    J Neurochem; 1994 Jan; 62(1):380-3. PubMed ID: 7505315
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Methamphetamine-induced decrease in neural glucocorticoid receptors: relationship to monoamine levels.
    Lowy MT; Novotney S
    Brain Res; 1994 Feb; 638(1-2):175-81. PubMed ID: 8199858
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HIV-1 protein Tat potentiation of methamphetamine-induced decreases in evoked overflow of dopamine in the striatum of the rat.
    Cass WA; Harned ME; Peters LE; Nath A; Maragos WF
    Brain Res; 2003 Sep; 984(1-2):133-42. PubMed ID: 12932847
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Augmentation of methamphetamine-induced toxicity in the rat striatum by unpredictable stress: contribution of enhanced hyperthermia.
    Tata DA; Raudensky J; Yamamoto BK
    Eur J Neurosci; 2007 Aug; 26(3):739-48. PubMed ID: 17686046
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparison of methylphenidate-, amphetamine-, and methamphetamine-induced hyperthermia and neurotoxicity in male Sprague-Dawley rats during the waking (lights off) cycle.
    Levi MS; Divine B; Hanig JP; Doerge DR; Vanlandingham MM; George NI; Twaddle NC; Bowyer JF
    Neurotoxicol Teratol; 2012 Mar; 34(2):253-62. PubMed ID: 22289608
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Methamphetamine-induced striatal dopamine neurotoxicity and cyclooxygenase-2 protein expression in BALB/c mice.
    Kita T; Shimada K; Mastunari Y; Wagner GC; Kubo K; Nakashima T
    Neuropharmacology; 2000 Jan; 39(3):399-406. PubMed ID: 10698006
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse.
    O'Callaghan JP; Miller DB
    J Pharmacol Exp Ther; 1994 Aug; 270(2):741-51. PubMed ID: 8071867
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers.
    Killinger BA; Moszczynska A
    J Neurochem; 2016 Feb; 136(3):510-25. PubMed ID: 26465779
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Behavioral consequences of methamphetamine-induced neurotoxicity in mice: relevance to the psychopathology of methamphetamine addiction.
    Itzhak Y; Ali SF
    Ann N Y Acad Sci; 2002 Jun; 965():127-35. PubMed ID: 12105090
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lowering ambient or core body temperature elevates striatal MPP+ levels and enhances toxicity to dopamine neurons in MPTP-treated mice.
    Moy LY; Albers DS; Sonsalla PK
    Brain Res; 1998 Apr; 790(1-2):264-9. PubMed ID: 9593931
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neurotoxic effects of chronic restraint stress in the striatum of methamphetamine-exposed rats.
    Quinton MS; Yamamoto BK
    Psychopharmacology (Berl); 2007 Aug; 193(3):341-50. PubMed ID: 17458543
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity.
    Hansen JP; Riddle EL; Sandoval V; Brown JM; Gibb JW; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2002 Mar; 300(3):1093-100. PubMed ID: 11861820
    [TBL] [Abstract][Full Text] [Related]  

  • 54. L-tetrahydropalmatine inhibits methamphetamine-induced locomotor activity via regulation of 5-HT neuronal activity and dopamine D3 receptor expression.
    Yun J
    Phytomedicine; 2014 Sep; 21(11):1287-91. PubMed ID: 25172791
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Methamphetamine-induced spectrin proteolysis in the rat striatum.
    Staszewski RD; Yamamoto BK
    J Neurochem; 2006 Mar; 96(5):1267-76. PubMed ID: 16417574
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison between the role of the neuronal and inducible nitric oxide synthase in methamphetamine-induced neurotoxicity and sensitization.
    Itzhak Y; Martin JL; Ali SF
    Ann N Y Acad Sci; 2000 Sep; 914():104-11. PubMed ID: 11085313
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo.
    Itzhak Y; Ali SF
    J Neurochem; 1996 Oct; 67(4):1770-3. PubMed ID: 8858965
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of subchronic methamphetamine exposure on basal dopamine and stress-induced dopamine release in the nucleus accumbens shell of rats.
    Broom SL; Yamamoto BK
    Psychopharmacology (Berl); 2005 Sep; 181(3):467-76. PubMed ID: 15986185
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux.
    Stephans SE; Yamamoto BK
    Synapse; 1994 Jul; 17(3):203-9. PubMed ID: 7974204
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dopamine uptake blockers nullify methamphetamine-induced decrease in dopamine uptake and plasma membrane potential in rat striatal synaptosomes.
    Westphalen RI; Stadlin A
    Ann N Y Acad Sci; 2000 Sep; 914():187-93. PubMed ID: 11085320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.